Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Interest & Investment Income (2016 - 2025)

Ptc Therapeutics has reported Interest & Investment Income over the past 14 years, most recently at -$55.2 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at -$55.2 million for Q4 2025, down 34.41% from a year ago — trailing twelve months through Dec 2025 was -$152.2 million (up 8.84% YoY), and the annual figure for FY2025 was -$152.2 million, up 8.84%.
  • Interest & Investment Income for Q4 2025 was -$55.2 million at Ptc Therapeutics, down from -$32.6 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for PTCT hit a ceiling of -$19.2 million in Q1 2021 and a floor of -$55.2 million in Q4 2025.
  • Median Interest & Investment Income over the past 5 years was -$28.8 million (2023), compared with a mean of -$31.3 million.
  • Biggest five-year swings in Interest & Investment Income: crashed 319.39% in 2021 and later soared 30.2% in 2025.
  • Ptc Therapeutics' Interest & Investment Income stood at -$22.5 million in 2021, then decreased by 8.88% to -$24.5 million in 2022, then plummeted by 80.71% to -$44.3 million in 2023, then rose by 7.26% to -$41.1 million in 2024, then tumbled by 34.41% to -$55.2 million in 2025.
  • The last three reported values for Interest & Investment Income were -$55.2 million (Q4 2025), -$32.6 million (Q3 2025), and -$30.4 million (Q2 2025) per Business Quant data.